Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05525741
NA

Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients

Sponsor: Centre Hospitalier Universitaire de Nice

View on ClinicalTrials.gov

Summary

To compare the level of circulating functional mitochondria in the serum of vitiligo patients as compared to controls

Official title: Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients as Compared to Controls

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

59

Start Date

2022-10-19

Completion Date

2025-06-30

Last Updated

2024-12-04

Healthy Volunteers

Yes

Interventions

OTHER

Non segmental vitiligo

The subjects will be selected from among those presenting for the consultation or hospitalization of the Dermatology department of the CHU de Nice. All necessary information will be given to the subjects and a briefing note will be given to them. A reflection period will be left for the subjects to sign the informed consent, and if necessary, another appointment will be scheduled for the inclusion visit. The Investigator: * Inform the subject of the goals, constraints and risks of the study and obtain written consent. * Conduct an examination of the subject's medical history Will verify that the subject meets all inclusion criteria and does not present any of the criteria for not including. If the subject consents and they meet all the criteria a 20 ml blood sample will be taken.

OTHER

Health Volunteers

The subjects will be selected from among those presenting for the consultation or hospitalization of the Dermatology department of the CHU de Nice. The family control subjects will be recruited from the vitiligos patients coming into our department. All necessary information will be given to the subjects and a briefing note will be given to them. A reflection period will be left for the subjects to sign the informed consent, and if necessary, another appointment will be scheduled for the inclusion visit. The Investigator: * Inform the subject of the goals, constraints and risks of the study and obtain written consent. * Conduct an examination of the subject's medical history Will verify that the subject meets all inclusion criteria and does not present any of the criteria for not including. If the subject consents and they meet all the criteria a 20 ml blood sample will be taken.

Locations (1)

CHU de Nice - Hôpital de l'Archet

Nice, Alpes-maritimes, France